Showing results (11-20 of 628) with videos related to

Sort By:
Pageof 63
Expert Opinion on Drug Safety|December 19, 2015
A Safety Evaluation of Cangrelor in Patients Undergoing PCIFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.
Progress in Cardiovascular Diseases|August 17, 2015
Novel Antiplatelet Agents: The Current State and What Is Coming Down the PikeFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.
Expert Opinion on Pharmacotherapy|June 17, 2016
Dual antiplatelet therapy after coronary stentingYongwhi Park, Francesco Franchi, Fabiana Rollini, et al.
Progress in Cardiovascular Diseases|January 2, 2018
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet TherapyJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|June 2, 2017
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to BedsideJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Translational Research|February 14, 2013
Platelet function profiles in patients with diabetes mellitusFabiana Rollini, Francesco Franchi, Ana Muñiz-Lozano, et al.
Therapeutic Advances in Cardiovascular Disease|July 3, 2013
Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practiceAna Muñiz-Lozano, Fabiana Rollini, Francesco Franchi, et al.
Expert Review of Hematology|November 2, 2017
The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shiftsJae Youn Moon, Francesco Franchi, Fabiana Rollini, et al.
Cardiovascular Diagnosis and Therapy|December 1, 2018
Diabetes and antiplatelet therapy: from bench to bedsideJose R Rivas Rios, Francesco Franchi, Fabiana Rollini, et al.
Vascular Health and Risk Management|April 15, 2014
Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxarJung Rae Cho, Fabiana Rollini, Francesco Franchi, et al.
Pageof 63